Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Marques A, Lambert C, Derost P, Beal C, Debilly B, Rieu I, Durif F

Open source

DOI
10.1016/j.neurol.2026.05.002
Published
2026 Sep
Container
Revue neurologique
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.neurol.2026.05.002,
  title = {Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?},
  author = {Marques A and Lambert C and Derost P and Beal C and Debilly B and Rieu I and Durif F},
  year = {2026},
  journal = {Revue neurologique},
  doi = {10.1016/j.neurol.2026.05.002},
  url = {https://doi.org/10.1016/j.neurol.2026.05.002}
}

RIS

TY  - JOUR
TI  - Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?
AU  - Marques A
AU  - Lambert C
AU  - Derost P
AU  - Beal C
AU  - Debilly B
AU  - Rieu I
AU  - Durif F
PY  - 2026
JO  - Revue neurologique
DO  - 10.1016/j.neurol.2026.05.002
UR  - https://doi.org/10.1016/j.neurol.2026.05.002
ER  - 

APA

A, M., C, L., P, D., C, B., B, D., I, R., & F, D. (2026). Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?. Revue neurologique. https://doi.org/10.1016/j.neurol.2026.05.002

Source records